This means tumors or cancer in the parts of your body that produce urine (like your kidneys and bladder) and the organs related to sex (like your genitals). It's a general term for cancers in these areas.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Genitourinary Tumors?
Genitourinary tumors are abnormal growths that start in the urinary tract or the reproductive organs. The urinary tract includes the kidneys, the ureters (the tubes that carry urine down to the bladder), the bladder and the urethra. The reproductive organs include the prostate, testicles and penis, and the ovaries, uterus, cervix, vagina and vulva. Some of these growths are benign, meaning they do not spread, but the term is most often used for cancers. This is an umbrella label rather than a single disease. Prostate, bladder, kidney and testicular cancer, and the cancers of the female reproductive organs, differ in who they affect, how they show up and how they are treated. Prostate cancer often grows slowly and may never cause harm, while testicular cancer tends to affect younger men and is usually curable. For any one person, what matters most is the organ involved, the type of cell the tumor started in and how far it has spread.
Each of these cancers has its own risk profile, but a few factors come up repeatedly. Smoking is a major risk factor for bladder and kidney cancer, and workplace exposure to certain chemicals also raises bladder cancer risk. Kidney cancer is also linked to excess body weight, high blood pressure and long-term misuse of pain medicines, including over-the-counter ones. Long-lasting infection with high-risk human papillomavirus (HPV), a very common virus spread through sexual contact, causes almost all cervical cancers and can also cause cancers of the vulva, vagina and penis. HPV vaccination prevents infection with the types most likely to cause cancer. Age raises the risk of most of these cancers, with testicular cancer the notable exception: it is most common between ages 20 and 39, and an undescended testicle increases the risk. Family history and inherited gene changes matter for some, such as changes in the BRCA1 and BRCA2 genes (also linked to breast cancer) for ovarian cancer, Lynch syndrome for uterine cancer and von Hippel-Lindau disease for kidney cancer. A risk factor raises the chance of cancer but does not mean it will develop.
How a tumor is found depends on where it is. Blood in the urine usually leads to urine tests, imaging such as a CT scan and often cystoscopy, in which a thin, lighted tube is passed through the urethra to look inside the bladder. A lump in a testicle is checked with an ultrasound and blood tests; if cancer is likely, the whole testicle is usually removed through a small cut in the groin rather than sampled with a needle. Abnormal vaginal bleeding, pelvic pain or a pelvic mass leads to a pelvic exam and imaging. For prostate cancer, the PSA (prostate-specific antigen) test measures a protein the prostate releases into the blood. A higher level can be a sign of cancer, but an enlarged prostate, inflammation and other causes can raise it too, so an abnormal result is usually followed by MRI and then a biopsy. Across these cancers, a diagnosis is confirmed by examining tissue under a microscope. Screening people without symptoms works differently for each cancer. Pap and HPV tests find cervical cell changes before they become cancer. PSA screening can find prostate cancer early, but it is not clear that this lowers the risk of dying from it, and it can lead to overdiagnosis: finding slow cancers that would never have caused harm, which may then be treated. No test has been shown to reduce deaths from ovarian cancer through screening. Once cancer is found, imaging and other tests establish its stage (how far it has spread) and grade (how abnormal the cells look), which guide treatment.
Treatment depends on the type, stage and grade of the cancer, a person's overall health and their preferences. The main approaches are surgery, radiation therapy, chemotherapy, hormone therapy, immunotherapy (which helps the immune system attack cancer) and targeted therapy (drugs aimed at specific features of cancer cells). Many people receive more than one. Some examples show how much the choices vary. Low-risk prostate cancer can often be managed with active surveillance: regular PSA tests, exams and repeat biopsies, with treatment only if the cancer grows. When prostate cancer needs treatment, surgery and radiation are common; both can cause erection problems and urine leakage. Hormone therapy for prostate cancer lowers or blocks the male hormones that fuel its growth. Early bladder cancer is usually removed through a cystoscope, often followed by medicine placed directly into the bladder to lower the chance of it coming back. If the whole bladder must be removed, surgeons create another way to store and pass urine, sometimes a pouch worn on the abdomen. Kidney cancer surgery may remove only the tumor to preserve kidney function. Testicular cancer is usually treated with surgery, sometimes followed by chemotherapy or radiation and is usually cured. Several of these treatments can cause infertility, which may be permanent. Anyone who may want children should ask about sperm banking or egg or embryo freezing before treatment begins. Clinical trials are an option worth asking about at many stages.
The outlook ranges widely. Many prostate cancers grow so slowly that people live for years with little or no treatment, and most testicular cancers are cured. Other genitourinary cancers are found later or behave more aggressively and need longer or repeated treatment. The care team can explain what the stage and grade mean for one person's situation. Treatment for cancers in this part of the body often affects urination, sexual function, fertility and body image. Some effects improve over months, such as bladder control after prostate surgery, while others are lasting and call for practical adjustments, such as caring for a urinary pouch. Pelvic floor exercises, treatments for erection problems and counseling can help, and these concerns are a normal part of follow-up conversations. Follow-up continues after treatment ends. Some of the tests used at diagnosis, such as PSA levels, cystoscopy or imaging, are repeated on a schedule to check that treatment worked and to catch any return early. After testicular cancer, regular self-checks of the other testicle matter because the risk there is higher.
See a clinician about blood in the urine, even once and even without pain, a lump or swelling in a testicle, vaginal bleeding after menopause or between periods, or a sore or growth on the penis. Urinary changes, such as a weak stream or frequent urination at night, or pain in the side, lower back or pelvis that does not go away also deserve an appointment, although they are often caused by something other than cancer. During chemotherapy or other treatment that lowers white blood cells, call the care team right away for a fever of 100.5°F (38°C) or higher, chills or other signs of infection, because infections at this time can become serious quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Genitourinary Tumors is like, what's helped you, or ask the community a question.